Matthew R Smith

In this discussion, Dr. Matthew R Smith, a medical oncologist from Massachusetts General Hospital, and Dr. Emmanuel S Antonarakis from the University of Minnesota, delve into the complexities of prostate cancer treatment. They explore the optimization of hormonal therapy and the potential of emerging therapies like PARP inhibitors and radioligand therapies. The conversation highlights the significance of biomarker testing, practical implications of PSMA PET findings, and the challenges of integrating novel approaches into clinical practice.